StockWatch
·
Pharmaceuticals
Board Meeting18 Jul 2026, 03:00 pm

Astonea Labs Board Meeting on July 24, 2026 for Audited Results

AI Summary

Astonea Labs Ltd has announced a Board of Directors meeting scheduled for July 24, 2026. The primary agenda items include the consideration and approval of the Audited Consolidated Financial Results for the Financial Year ended March 31, 2026. The meeting will also address the Notice for the 9th Annual General Meeting, the Annual Report for FY 2025-26, proposed alterations to the Memorandum of Association, and the incorporation of a new subsidiary. The trading window for company shares remains closed until 48 hours after the declaration of the consolidated financial results.

Key Highlights

  • Board meeting scheduled for July 24, 2026.
  • To approve Audited Consolidated Financial Results for FY 2025-26.
  • Agenda includes AGM notice, Annual Report, MOA alteration.
  • Consideration for subsidiary incorporation and investment.
  • Trading window closed until results announcement.